The US mail order pharmacy market size is expected to grow from US$ 43.728.62 million in 2022 to US$ 1,71,883.03 million by 2030; it is estimated to register a CAGR of 18.66% from 2022 to 2030.
Analyst’s ViewPoint
The US mail order pharmacy market analysis sheds light on the key factors enabling its growth; these include the increasing incidences of chronic diseases and surging adoption of mail order pharmacy services for different healthcare needs. Further, the integration of artificial intelligence (AI) in retail pharmacies is expected to emerge as a new trends in the market during 2022–2030. Based on drug type, the US mail order pharmacy market is bifurcated into non-prescription drugs and prescription drugs. The prescription drugs segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022–2030. The US mail order pharmacy market, by product, is segmented into dermal care products, anti-diabetic medicines, cardiovascular medicines, blood pressure medicines, asthma management products, cold & flu medicines, painkillers, antacids, and others. The dermal care products segment held the largest market share in 2022, and the cardiovascular medicines segment is anticipated to register the highest CAGR during 2022–2030. Based on the mode of order, the US mail order pharmacy market is categorized into online stores and pharmacy apps. The online store segment is expected to account for a maximum share of the market during 2022–2030.
Mail-order pharmacy makes it easy to manage medication ordering and refill using a computer or a smartphone. Medications are ordered by mail order pharmacy less expensive and can be covered in a health plan. The insurer can buy medications in large quantities directly from drug manufacturers at lower costs.
Market Insights
Increasing Incidences of Chronic Diseases Drive US Mail Order Pharmacy Market Growth
Chronic diseases such as diabetes, cardiovascular disorders, autoimmune disorders, and various cancer types are the leading causes of mortality worldwide. According to the National Association of Chronic Disease Directors 2022 report, nearly 40% of American adults have multiple chronic conditions (MCC). Additionally, the National Health Council report reveals that chronic conditions account for more than 75% of the total healthcare costs in the US. Heart disease, cancer, mental disorders, and pulmonary conditions rank among the 5 most expensive health conditions, based on total annual healthcare spending in the US. Similarly, diabetes is one of the life-threatening chronic diseases with no functional cure. All types of diabetes may lead to complications in different body parts and trigger the overall risk of premature death. According to a report published by the Centers for Disease Control and Prevention (CDC), a total of 37.3 million people in the US (i.e., 11.3% of the US population) suffer from diabetes every year, including 8.5 million (23.0% of adults) undiagnosed cases and 28.7 million (28.5 million adults) diagnosed cases. Medication adherence among chronic disease patients can offer better health outcomes, with a reduction in hospitalizations and costs. Non-adherence to inhaled corticosteroids is responsible for ~24% of asthma exacerbations. There have been many attempts to increase medication adherence and improve patient care in the US. Various insurance companies provide financial incentives to encourage customers to fill prescriptions via mail-order pharmacies, which proves less expensive for patients. Mail-order pharmacy services are typically offered for buying drugs prescribed for chronic conditions such as high cholesterol, asthma, high blood pressure, diabetes, and depression. Through this pharmacy model, customers can receive medicines for 90 days rather than getting prescriptions refilled every month. Therefore, in addition to the increasing incidences of chronic diseases—medication nonadherence, population aging, and convenience over traditional methods drive growth of the US mail order pharmacy market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
US Mail Order Pharmacy Market: Strategic Insights
Market Size Value in US$ 43.728.62 million in 2022 Market Size Value by US$ 1,71,883.03 million by 2030 Growth rate CAGR of 18.66% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
US Mail Order Pharmacy Market: Strategic Insights
| Market Size Value in | US$ 43.728.62 million in 2022 |
| Market Size Value by | US$ 1,71,883.03 million by 2030 |
| Growth rate | CAGR of 18.66% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Future Trend
Integration of Artificial Intelligence (AI) in Retail Pharmacies
As consumers continue to prioritize their health and wellness, retail pharmacies are keen to adopt new technologies to streamline the process and enhance consumer convenience. They focus on improving their services, reducing costs, and optimizing stock availability through the integration of AI tools into their operations. AI integration provides a competitive advantage and can guide patients through the specialty prescription filling process, thereby aiding in the convenience of buying. In April 2019, Amazon launched the upgraded line of Amazon Alexa enabled to execute HIPAA-compliant healthcare services such as storing blood sugar measurements and providing prescription delivery updates.
Many retail pharmacy giants are partnering with AI companies to improve patient care. The trend of AI integration is picking pace among pharmacy chains. In April 2023, Express Scripts launched its new "ClearCareRx" model, which has been designed to increase access to affordable medicines, and drive transparency and predictability. Additionally, Express Scripts is working closely with healthcare providers and health plan clients to offer consultative options to bring affordable medicines to consumers. Also, Express Scripts provides a broader list of preventive prescribed drugs that are fully covered at discounts, lower premiums, and deductibles by increasing Health Savings Account contributions. Thus, collaborations between mail-order pharmacies and AI companies are likely to benefit the US mail order pharmacy market in the coming years.
Report Segmentation and Scope
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Drug Type-Based Insights
Based on drug type, the US mail order pharmacy market is bifurcated into non-prescription drugs and prescription drugs. The prescription medicine segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 19.11% 2020-2030. Mail order pharmacies dispense drugs based on genuine outpatient prescriptions provided by medical professionals. They require prescriptions for dispensing drugs such as cancer medication, cardiovascular drugs, and diabetes drugs. The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes, and the rising cases of orphan diseases are likely to benefit the US mail order pharmacy market for the prescription drugs segment. Moreover, flourishing R&D activities and high healthcare expenditure contribute notably to the market growth of this segment. Prominent prescription drugs required in the US are oncology drugs, followed by respiratory agents such as anti-inflammatory drugs, lung fluid replacement drugs, decongestants, biologics, and inhaled corticosteroids. Lipid regulators occupy the third place among the major prescription drugs.
Many online pharmacy platforms are offering prescription drug delivery services. The demand for mail order medicines is on the rise due to the increasing reach of e-commerce platforms and Internet services. Many online pharmacies across the US offer doorstep deliveries and are also involved in the dispensing of prescription medicines. In July 2023, CVS Caremark and GoodRx launched Caremark Cost Saver, a prescription drug discount solution to help lower costs and improve the experience for a vast number of CVS Caremark members.
Product-Based Insights
Based on product, the US mail order pharmacy market is segmented into dermal care products, anti-diabetic medicines, cardiovascular medicines, blood pressure medicines, asthma management products, cold & flu medicines, painkillers, antacids, and others. The dermal care product segment held the largest market share in 2022, and the cardiovascular medicines segment is anticipated to register the highest CAGR of 22.89% during 2020-2030. Increasing demand for face creams, sunscreens, and body lotions, and the growing adoption of e-commerce platforms are expected to favor the US mail order pharmacy market progress during the forecast period. These pharmacies offer dermal care products with better pricing than local pharmacy stores. Moreover, a large range of dermal care products, including sunscreens, anti-aging creams, body lotions, and skin-brightening creams, are made available via these platforms. Skincare products are available with better access, lower transaction and product costs, greater convenience, and optimum anonymity. According to an article published by McKinsey & Company in May 2023, the e-commerce business in the beauty segment nearly quadrupled from 2015 to 2022, with its share exceeding 20%. Rising awareness about the benefits of dermal care products has increased their demand over the last few years. Moreover, natural and organic skincare products have gained significant popularity in recent times, making it a leading segment of the cosmetics and wellness industry. Thus, the progressive cosmetics and wellness industry in the US favors the growth of the mail order pharmacy market for the dermal care segment.
In the US, the prevalence of chronic heart diseases due to sedentary lifestyles has been rising steadily, resulting in a high incidence of cardiovascular disorders. Moreover, the growing geriatric population diagnosed with cardiovascular disorders is fueling the demand for medications for treating these diseases across the US. According to the Heart Failure Society of America, in 2020, the US reported an increased number of heart failure patients admitted twice or multiple times due to the lack of care coordination. This upsurge is attributed to the unavailability of consistent care providers, lack of follow-up care, and the availability of means to track blood pressure and weight at home. The Heart Failure Society of America (AHA) also revealed that medications were the leading cause of readmissions. Hence, the considerable target population is positively impacting the growth of the mail order pharmacy market for the cardiovascular medicines segment. Medications such as anti-ischemic, anti-anginal, and cardiac glycosides are widely distributed through online prescription pharmacy services. Ordering prescription drugs for cardiovascular conditions through mail order pharmacies is convenient, and it contributes to better drug adherence. Studies show that cardiac patients using mail order medication services show adherence rates of 84.7%, compared to local pharmacy users at 76.9%. Such a high adherence rate can be attributed to 90-day prescription refills offered by mail order pharmacies, home delivery services, and 24/7 pharmacist support. For instance, Kaiser Permanente patients on cholesterol control therapy achieved better control and obtained their statin prescription through mail order pharmacies for the first 3–15 months.
Mode of Order-Based Insights
In terms of mode of order, the US mail order pharmacy market is categorized into online stores and pharmacy apps. The online store segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 19.08% during 2020-2030. Many pharmaceutical companies in the US are adopting online pharmacy models to grow their businesses in the healthcare sector. Pharmacies such as Lloyads Pharmacy and HeathWareHouse.com provide home delivery services through their online stores in the US. Online pharmacy stores allow consumers to purchase medicines without visiting brick-and-mortar pharmacies, ensuring greater convenience for consumers, which has resulted in a rising demand for this store model across the country. Medical practitioners across the country now prefer e-prescriptions to provide patients with easy access to medicines. One can easily upload their e-prescriptions on e-pharmacy websites, order medicine online, and get medications delivered at the desired location.
Highly developed IT infrastructure, an increase in smartphone adoption, and penetration of high-speed internet in urban and rural areas bolster the market for the online pharmacy store segment. Increasing initiatives taken by various nations to make prescription medicines readily available at affordable prices also drive the demand for online pharmacy stores.
US Mail Order Pharmacy Market, by Drug Type – 2022 and 2030
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Country Analysis
The US mail order pharmacy market is expected to reach US$ 1,71,883.03 million in 2030 from US$ 43,728.62 million in 2022. The market is estimated to grow at a CAGR of 18.66% from 2022 to 2030. Mail-order pharmacies dispense medicines referring to outpatient prescriptions. These types of pharmacies focus on distributing maintenance prescriptions leading to the majority of outpatient prescription sales in the US. These types of pharmacies provide patients with online ordering services for refills with the convenience of home delivery and an extensive supply chain, compared to community pharmacies. Mail-order pharmacies often cost less for patients, but they prove expensive for health plan providers. According to an article published in the American Journal of Preventive Medicine in 2021, the share of mail-order pharmacies in the outpatient prescription market in the US surged from 6% in 1989 to 15.2% in 2013. However, the adoption of mail-order pharmacies has reduced in recent years; the share dropped to 9.5% of the outpatient prescriptions dispensed in 2019.
The growing competition among community pharmacies and favorable policies related to mail-order pharmacies are anticipated to boost the growth of the US mail order pharmacy market in the coming years. Companies such as Amazon, which provide mail-order services, represent a rising threat to retail pharmacies. Mail-order pharmacy in the US has taken hold and grown over the last decade, currently mailing products based on billions of prescriptions every year.
According to data obtained from the CDC, ~3.8 billion prescriptions are written annually. Among those filled prescriptions, approximately 50% are misinterpreted in terms of timing, dosage, frequency, and duration. The US Department of Veteran Affairs (VA) runs programs benefiting veterans and members of their families. It offers Pharmacy Benefit Management Services that account for approximately ~80% of outpatient prescriptions filled via VA and sent by mail order using the Centralized Mail Order Pharmacy (CMOP) network of highly automated pharmacies in the country. Companies such as Walgreens, CVS, and Amazon are transforming their e-commerce operations into digital delivery platforms by launching new services. For instance, in November 2020, Amazon launched Amazon Pharmacy, an online and mobile prescription medication ordering and fulfillment service. On this platform, customers can add their insurance details, choose payment options, and manage prescriptions.
The report profiles leading players operating in the US mail order pharmacy market. These include CVS Health Corp, Walmart Inc, Envirotainer AB, Able Freight Services LLC, Deutsche Post AG, GeniusRx, Geisinger Health, Cornerstone Health Solutions LLC, Humana Inc, Ridgeway Pharmacy LLC, and The Cigna Group.
- In July 2023, CVS Caremark and GoodRx launched Caremark Cost Saver to assist CVS Caremark clients in lowering out-of-pocket prescription costs. CVS Caremark qualified members receive automatic access to GoodRx prescription pricing, allowing them to pay lower costs on generic pharmaceuticals.
- In October 2021, GeniusRx launched GeniusClinic and GeniusIQ to provide consumers with access to prescription drugs in a transparent and affordable manner. The GeniusIQ is a machine learning platform for refill and new medications prescribed for non-acute and lifestyle conditions.
Company Profiles
- CVS Health Corp
- Walmart Inc
- Envirotainer AB
- Able Freight Services LLC
- Deutsche Post AG
- GeniusRx
- Geisinger Health
- Cornerstone Health Solutions LLC
- Humana Inc
- Ridgeway Pharmacy LLC
- The Cigna Group
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Drug Type, Product, and Mode of Order
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Key factors that are driving the growth of this market are increasing incidences of chronic diseases and increasing adoption of mail order pharmacy services for specific healthcare needs to boost the market growth for the US Mail-Order Pharmacy over the years.
Prescription medicine segment held the largest share of the market in the US mail-order pharmacy and held the largest market share in 2022.
Mail-order pharmacy makes it easy to manage medication ordering and refill using a computer or a smartphone. Medications are ordered by mail order pharmacy less expensive and are operated through health plan. The insurer can buy medications in large quantities directly from drug manufacturers to lower costs.
The CAGR value of the US Mail-Order Pharmacy during the forecasted period of 2023-2028 is 18.66%.
CVS Health Corp and GeniusRx are the top two companies that hold huge market shares in the US mail-order pharmacy.
The dermal care segment dominated the US mail-order pharmacy and held the largest market share in 2022.
The US mail-order pharmacy majorly consists of the players such CVS Health Corp, Walmart Inc, Envirotainer AB, Able Freight Services LLC, Deutsche Post AG, GeniusRx, Geisinger Health, Cornerstone Health Solutions LLC, Humana Inc, Ridgeway Pharmacy LLC, and The Cigna Group, and among others. .
The List of Companies - US Mail Order Pharmacy Market
- CVS Health Corp
- Walmart Inc
- Envirotainer AB
- Able Freight Services LLC
- Deutsche Post AG
- GeniusRx
- Geisinger Health
- Cornerstone Health Solutions LLC
- Humana Inc
- Ridgeway Pharmacy LLC
- The Cigna Group
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to US Mail Order Pharmacy Market
Oct 2023
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2023
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2023
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2023
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2023
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2023
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Oct 2023
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Oct 2023
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)